OLYMPUS Corp/S (OTCMKTS:OCPNY) – Equities researchers at Jefferies Financial Group cut their FY2019 EPS estimates for OLYMPUS Corp/S in a report released on Tuesday, November 20th. Jefferies Financial Group analyst M. Nakanomyo now anticipates that the company will post earnings of $0.72 per share for the year, down from their prior estimate of $1.07.
A number of other brokerages have also weighed in on OCPNY. ValuEngine upgraded OLYMPUS Corp/S from a “hold” rating to a “buy” rating in a research note on Wednesday, September 26th. Zacks Investment Research lowered OLYMPUS Corp/S from a “hold” rating to a “sell” rating in a research note on Wednesday, October 24th.
About OLYMPUS Corp/S
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.
Receive News & Ratings for OLYMPUS Corp/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS Corp/S and related companies with MarketBeat.com's FREE daily email newsletter.